½ÃÀ庸°í¼­
»óǰÄÚµå
1261213

¼¼°èÀÇ °ü°­³» ºÀÇÕ ±â±â ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2022-2029³â)

Global Endoluminal Suturing Devices Market Size study & Forecast, by Application, by End-User and Regional Analysis, 2022-2029

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Àü¼¼°è ¼ö¹é¸¸ ¸íÀÌ º´À» ¾Î°í ÀÖÀ¸¸ç, ÇöÀç ¼¼°èÀÇ À¯ÇàÀÌ µÇ°í ÀÖ´Â ºñ¸¸¿¡ ºñ¸¸ ³»½Ã°æÀ» ÀÌ¿ëÇÑ ÇコÄɾî´Â ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ ²ÙÁØÈ÷ ±× ¼±ÅÃÁö¸¦ ´Ã·Á¿À°í ÀÖ½À´Ï´Ù .

ºÀÇÕ ¹× ½ºÅ×ÀÌÇøµÀ» À§ÇÑ Àåºñ´Â ÁÖ·Î GERD ¹× ºñ¸¸°ú °ü·ÃµÈ ÀÇ·á ÀýÂ÷¿¡ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ µµÀÔÀº ÃÖ¼Òħ½ÀÀûÀÎ ÀÓ»ó Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â °ÍÀÌ ÁÖ¿ä ÀÌÁ¡ÀÔ´Ï´Ù. Áß¿äÇÑ Áøº¸·Î ÀÎÇØ ÀÓ»ó½ÃÇè°ú Ä¡·á¹ýÀÇ Áøº¸´Â °ú°Å¿¡´Â ÃÖ±Ù ¸î ³â µ¿¾È ´õ ´À¸° ¼Óµµ·Î ÁøÇàµÇ¾ú½À´Ï´Ù. ³»½Ã°æ ¼ö¼ú¿¡¼­ ÀÇ»ç´Â °ü°­³» ºÀÇÕ ±â±â¸¦ ÀÚÁÖ »ç¿ëÇÕ´Ï´Ù. °ü°­³» ºÀÇÕ ±â±â´Â À¯¿¬ÇÑ ºÀÇÕ±âÀÇ µµ¿òÀ¸·Î µÎ²¨¿î ºÀÇջ縦 ¿øÇÏ´Â ºÎÀ§¿¡ ³Ö´Â µ¥ »ç¿ëµË´Ï´Ù. ³»½Ã°æ ¼ö¼ú¿¡ »ç¿ëµÇ´Â À¯¿¬ÇÑ ÀÛÀº Ư¼ö ºÀÇÕ±âÀÔ´Ï´Ù. °ü°­³» ºÀÇÕ ±â±â´Â ȸº¹·üÀÌ ³ô°í, ÃÖ¼Òħ½ÀÀûÀÎ ÀÇ·á óġÀÇ ¼ö¿ä¸¦ ÃæÁ·½ÃŰ´Â °ÍÀ¸·Î, ȯÀÚÀÇ Ã¼ÇèÀ» Çâ»ó½ÃÄÑ, ȸº¹ ½Ã°£ÀÇ ´ÜÃà, Åë¿ø ȸ¼öÀÇ °¨¼Ò, ÀÔ¿ø ±â°£ÀÇ ´ÜÃàÀ¸·Î À̾îÁý´Ï´Ù. ¶ÇÇÑ, ·ç¸à ºÀÇÕ ÀåÄ¡ÀÇ ¼ö¿ë¼ºÀº °í±Þ ±â±¸ÀÇ »ç¿ë¿¡ ÀÇÇØ Á¶ÀåµË´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀº ÃÖ¼Òħ½À ¼ö¼ú Áõ°¡, ¼ö¼ú ¼ö¿ä Áõ°¡, ¸¸¼º ÁúȯÀÇ Áõ·Ê Áõ°¡ÀÔ´Ï´Ù.

¼¼°è ¼ö¼úÀÇ Áõ°¡·Î ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå¿¡ À¯¸®ÇÑ ¼ö¿ä°¡ ¹ß»ýÇß½À´Ï´Ù. °³º¹ ¼ö¼ú, ³»½Ã°æ ¼ö¼ú, º¹ºÎ ¼ö¼ú ¹× ±âŸ ¼ÒÈ­±â ¼ö¼ú¿¡¼­´Â ·ç¸à ºÀÇÕ ÀåÄ¡°¡ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ¼ö¼ú Ä¡·áÀÇ ÇÕ¸®ÀûÀÎ °¡°Ý°ú Á¢±Ù¼ºÀº ½Ã´ë¿Í ÇÔ²² °³¼±µÇ¾î ºÀÇÕ Àåºñ¸¦ »ç¿ëÇÏ´Â ¼ö¼ú ¼ö°¡ Å©°Ô Áõ°¡Çß½À´Ï´Ù. »ýȰ ½À°üº´ÀÇ À¯º´·ü Áõ°¡¿Í ¼ö¼ú ¼ö¼úÀÇ Áõ°¡·Î ÀÎÇØ ºÀÇձ⸦ Æ÷ÇÔÇÑ ÃÖ÷´Ü ¼ö¼ú Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. Statista¿¡ µû¸£¸é 2019³â ¼¼°è ħ½À ¼ö¼ú ½ÃÀåÀº 205¾ï ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2030³â¿¡´Â 440¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¼¼°èº¸°Ç±â±¸(WHO)´Â 2019³â Àü¼¼°è ¿¬°£ 2¾ï 3,500¸¸ ´Þ·¯ÀÇ ´ë¼ö¼úÀÌ ½Ç½ÃµÇ¾ú´Ù°í º¸°íÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¿Ü·¡ ¼ö¼úÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â °ÍÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÀåÄ¡ »ç¿ëÀÇ ¾î·Á¿ò°ú ·ç¸à ºÀÇÕ ÀåÄ¡ÀÇ ³ôÀº ºñ¿ëÀº 2022³âºÎÅÍ 2029³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù.

°ü°­³» ºÀÇÕ ±â±â ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÇ´Â ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì, ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« ¹× ¼¼°è ±âŸ Áö¿ªÀÔ´Ï´Ù. ºÏ¹Ì´Â ¼ö¼úÀ» À§ÇÑ ´ë±Ô¸ð ȯÀÚ ¼ö¿µÀåÀÇ Á¸Àç¿Í ÀÌ Áö¿ªÀÇ À¯¸®ÇÑ »óȯ Á¤Ã¥À» ÅëÇØ ½ÃÀå Á¡À¯À² Ãø¸é¿¡¼­ ¼¼°èÀûÀ¸·Î Áö¹èÀûÀÎ Áö¿ªÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇÑÆí ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·áÀÎÇÁ¶ó Á¤ºñ¿¡ Á¤ºÎ°¡ ÈûÀ» ½ñ°í ÀÖ´Â °Í, ¸¸¼ºÁúȯÀ̳ª °¨¿°Áõ¿¡ °É¸®±â ½¬¿î Àα¸°¡ Áõ°¡Çϰí ÀÖ´Â µîÀ¸·Î ¿¹Ãø±â°£ Áß °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÌ¸é ¿¹»óµÇ°í ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °ü°­³» ºÀÇÕ ±â±â ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀå Àü¸ÁÀ» âÃâÇϰí ÀÖ½À´Ï´Ù.

º» ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®¿Í ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ¹àÈ÷°í ¾ÕÀ¸·Î ¼ö³â°£ÀÇ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» ÅëÇÕÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ¸¶ÄÏ ½º³À¼¦
  • ¼¼°è¡¤ºÎ¹®º° ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
    • °ü°­³» ºÀÇÕ ±â±â ½ÃÀå, Áö¿ªº°, 2019-2029³â
    • °ü°­³» ºÀÇÕ ±â±â ½ÃÀå, ¿ëµµº°, 2019-2029³â
    • °ü°­³» ºÀÇÕ ±â±â ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2029³â
  • ÁÖ¿ä µ¿Çâ
  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ °¡Á¤

Á¦2Àå °ü°­³» ºÀÇÕ ±â±â ¼¼°è ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • Á¶»ç ´ë»ó ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
  • º» Á¶»çÀÇ ´ë»óÀÌ µÈ ÇØ
  • ȯÀ² º¯È¯À²

Á¦3Àå °ü°­³» ºÀÇÕ ±â±â ¼¼°è ½ÃÀå ¿ªÇÐ

  • °ü°­³» ºÀÇÕ ±â±â ½ÃÀåÀÇ ¿µÇ⠺м®(2019-2029³â)
    • ½ÃÀå ÃËÁø¿äÀÎ
      • ÃÖ¼Òħ½À ¼ö¼ú Áõ°¡
      • ¸¸¼ºÁúȯ ȯÀÚ¼ö Áõ°¡
    • ½ÃÀåÀÇ °úÁ¦
      • °ü°­³» ºÀÇÕ ±â±âÀÇ °íºñ¿ëÈ­
    • ½ÃÀå ±âȸ
      • ¿Ü·¡ ¼ö¼úÀÇ µµÀÔÀÌ ÁøÇàµÈ´Ù

Á¦4Àå °ü°­³» ºÀÇÕ ±â±â ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's 5 Force ¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù(2019-2029³â)
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • ¼Ò¼È
    • Å×Å©´ÏÄÃ
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ¾÷°è °ü°èÀÚ Àü¸Á
  • ¾Ö³Î¸®½ºÆ®ÀÇ ±Ç°í¿Í °á·Ð

Á¦5Àå À§Çè Æò°¡: COVID-19ÀÇ ¿µÇâ

  • COVID-19°¡ ¾÷°è¿¡ ¹ÌÄ¡´Â ÀüüÀûÀÎ ¿µÇâ¿¡ ´ëÇÑ Æò°¡
  • COVID-19 ÀÌÀü°ú COVID-19 ÀÌÈÄÀÇ ½ÃÀå ½Ã³ª¸®¿À

Á¦6Àå °ü°­³» ºÀÇÕ ±â±â ¼¼°è ½ÃÀå : ¿ëµµº°

  • ¸¶ÄÏ ½º³À¼¦
  • °ü°­³» ºÀÇÕ ±â±â ¼¼°è ½ÃÀå : ¿ëµµ, ½ÇÀû - ÀáÀç ´É·Â ºÐ¼®
  • °ü°­³» ºÀÇÕ ±â±â ¼¼°è ½ÃÀå ÃßÁ¤¡¤¿¹Ãø(¿ëµµº°) 2019-2029
  • °ü°­³» ºÀÇÕ ±â±â ½ÃÀå, ¼­ºê ºÎ¹®º° ºÐ¼®
    • ºñ¸¸ ¼ö¼ú
    • ¼ÒÈ­±â ¼ö¼ú
    • À§½Äµµ¿ª·ùÁúȯ ¼ö¼ú
    • ±âŸ ¼ö¼ú

Á¦7Àå °ü°­³» ºÀÇÕ ±â±â ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¸¶ÄÏ ½º³À¼¦
  • °ü°­³» ºÀÇÕ ±â±â ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • °ü°­³» ºÀÇÕ ±â±â ¼¼°è ½ÃÀå ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • °ü°­³» ºÀÇÕ ±â±â ½ÃÀå, ¼­ºê ºÎ¹®º° ºÐ¼®
    • º´¿ø
    • Ŭ¸®´Ð
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
    • ±âŸ

Á¦8Àå °ü°­³» ºÀÇÕ ±â±â ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

  • °ü°­³» ºÀÇÕ ±â±â ½ÃÀå, Áö¿ªº° ¸¶ÄÏ ½º³À¼¦
  • ºÏ¹Ì
    • ¹Ì±¹
      • ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
      • ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
    • ij³ª´Ù
  • À¯·´ÀÇ °ü°­³» ºÀÇÕ ±â±â ½ÃÀå ½º³À¼¦
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °ü°­³» ºÀÇÕ ±â±â ½ÃÀå ½º³À¼¦
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ °ü°­³» ºÀÇÕ ±â±â ½ÃÀå ½º³À¼¦
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • ¼¼°è ±âŸ Áö¿ª

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Apollo Endosurgery, Inc.
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍÀÇ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì¸¸)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Johnson & Johnson
    • Medtronic Plc
    • Cook Group Incorporated
    • USGI Medical
    • Ovesco Endoscopy AG
    • Endo Tools Therapeutics SA
    • ErgoSuture
    • Sutrue Ltd.
    • Stryker Corporation

Á¦10Àå Á¶»ç ÇÁ·Î¼¼½º

  • Á¶»ç ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • ¹ë¸®µ¥À̼Ç
    • ÃâÆÇ
  • Á¶»çÀÇ Æ¯Â¡
  • Á¶»çÀÇ °¡Á¤
ksm 23.04.28

Global Endoluminal Suturing Devices Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Therapeutic therapies using bariatric endoscopy to combat obesity, which affects millions of people worldwide and has now become a global pandemic, are steadily has become the preferred option in a variety of healthcare settings. Devices for suturing and stapling are mostly used in medical procedures related to GERD and obesity. The primary benefit is that these devices' implementation allows for minimally invasive clinical treatments. Due to significant advancements, clinical trials and treatments have traditionally advanced at a slower rate than in recent years. For endoscopic procedures, physicians frequently use endoluminal suturing devices, which are used to put thick sutures in the intended area with the aid of flexible sutures. A tiny, specialized suturing device used in endoscopic surgery that has flexibility. Endoluminal suturing devices provide a higher rate of recovery and satisfy demand for minimally invasive medical procedures, which improves patient experience and results in faster recovery times, fewer hospital visits, and shorter stays in hospitals. The acceptability of endoluminal suturing devices has also been aided by the use of advanced instruments. The key factors driving the market growth are rising minimally invasive operations, growing demand for surgeries, and growing cases of chronic diseases.

The increasing number of surgical procedures globally is creating a lucrative demand for the market during forecast period. Open surgeries, endoscopy, abdominal surgeries, and other gastrointestinal surgeries frequently use endoluminal suturing devices. The affordability and accessibility of surgical treatment have improved over time, which has resulted in a large increase in the number of surgical procedures involving suturing devices. The demand for cutting-edge surgical equipment, including suturing devices, has expanded further as a result of the rising prevalence of lifestyle illnesses and the ensuing increase in surgical procedures. According to Statista, in 2019, the minimally invasive surgery market globally was valued at USD 20.5 billion and it is anticipated to reach USD 44.04 billion by 2030. Also, the World Health Organization (WHO) reported that 235 million major surgeries were performed annually over the world in 2019. Additionally, rising adoption of outpatient surgeries is creating a lucrative opportunity for the market during forecast period. However, the difficulties of using the devices and high cost of Endoluminal Suturing Devices stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Endoluminal Suturing Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of large patient pool for surgery and favorable reimbursement policies in the region. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as government concentration on improving healthcare infrastructure and increasing number of population prone to chronic disease and infectious diseases would create lucrative growth prospects for the Endoluminal Suturing Devices market across Asia Pacific region.

Major market players included in this report are:

  • Apollo Endosurgery, Inc.
  • Johnson & Johnson
  • Medtronic Plc
  • Cook Group Incorporated
  • USGI Medical
  • Ovesco Endoscopy AG
  • Endo Tools Therapeutics S.A.
  • ErgoSuture
  • Sutrue Ltd.
  • Stryker Corporation

Recent Developments in the Market:

  • In Dec. 2020, Apollo Endo-surgery, Inc. announced that Reshape Lifesciences would buy its surgical product line for laparoscopic bariatric surgery. Apollo's variety of endo-bariatric products will increase as a result.

Global Endoluminal Suturing Devices Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Application, End-User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Application:

  • Bariatric Surgery
  • Gastrointestinal Surgery
  • Gastroesophageal Reflux Disease Surgery
  • Other Surgeries

By End-User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Other

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Endoluminal Suturing Devices Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Endoluminal Suturing Devices Market, by Application, 2019-2029 (USD Billion)
    • 1.2.3. Endoluminal Suturing Devices Market, by End-User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Endoluminal Suturing Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Endoluminal Suturing Devices Market Dynamics

  • 3.1. Endoluminal Suturing Devices Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising minimally invasive operations
      • 3.1.1.2. Growing cases of chronic diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Endoluminal Suturing Devices
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising adoption of outpatient surgeries

Chapter 4. Global Endoluminal Suturing Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Endoluminal Suturing Devices Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Endoluminal Suturing Devices Market by Application, Performance - Potential Analysis
  • 6.3. Global Endoluminal Suturing Devices Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 6.4. Endoluminal Suturing Devices Market, Sub Segment Analysis
    • 6.4.1. Bariatric Surgery
    • 6.4.2. Gastrointestinal Surgery
    • 6.4.3. Gastroesophageal Reflux Disease Surgery
    • 6.4.4. Other Surgeries

Chapter 7. Global Endoluminal Suturing Devices Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global Endoluminal Suturing Devices Market by End-User, Performance - Potential Analysis
  • 7.3. Global Endoluminal Suturing Devices Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
  • 7.4. Endoluminal Suturing Devices Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Clinics
    • 7.4.3. Ambulatory Surgical Centers
    • 7.4.4. Other

Chapter 8. Global Endoluminal Suturing Devices Market, Regional Analysis

  • 8.1. Endoluminal Suturing Devices Market, Regional Market Snapshot
  • 8.2. North America Endoluminal Suturing Devices Market
    • 8.2.1. U.S. Endoluminal Suturing Devices Market
      • 8.2.1.1. Application breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End-User breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Endoluminal Suturing Devices Market
  • 8.3. Europe Endoluminal Suturing Devices Market Snapshot
    • 8.3.1. U.K. Endoluminal Suturing Devices Market
    • 8.3.2. Germany Endoluminal Suturing Devices Market
    • 8.3.3. France Endoluminal Suturing Devices Market
    • 8.3.4. Spain Endoluminal Suturing Devices Market
    • 8.3.5. Italy Endoluminal Suturing Devices Market
    • 8.3.6. Rest of Europe Endoluminal Suturing Devices Market
  • 8.4. Asia-Pacific Endoluminal Suturing Devices Market Snapshot
    • 8.4.1. China Endoluminal Suturing Devices Market
    • 8.4.2. India Endoluminal Suturing Devices Market
    • 8.4.3. Japan Endoluminal Suturing Devices Market
    • 8.4.4. Australia Endoluminal Suturing Devices Market
    • 8.4.5. South Korea Endoluminal Suturing Devices Market
    • 8.4.6. Rest of Asia Pacific Endoluminal Suturing Devices Market
  • 8.5. Latin America Endoluminal Suturing Devices Market Snapshot
    • 8.5.1. Brazil Endoluminal Suturing Devices Market
    • 8.5.2. Mexico Endoluminal Suturing Devices Market
    • 8.5.3. Rest of Latin America Endoluminal Suturing Devices Market
  • 8.6. Rest of The World Endoluminal Suturing Devices Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Apollo Endosurgery, Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Johnson & Johnson
    • 9.2.3. Medtronic Plc
    • 9.2.4. Cook Group Incorporated
    • 9.2.5. USGI Medical
    • 9.2.6. Ovesco Endoscopy AG
    • 9.2.7. Endo Tools Therapeutics S.A.
    • 9.2.8. ErgoSuture
    • 9.2.9. Sutrue Ltd.
    • 9.2.10. Stryker Corporation

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦